echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Hypoxia promotes linear ubiquitination of AGO2 to regulate tumorigenesis and development

    Hypoxia promotes linear ubiquitination of AGO2 to regulate tumorigenesis and development

    • Last Update: 2021-09-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Tumor hypoxic microenvironment is one of the most significant characteristics of solid tumors


    On September 13, 2021, the team of Yu Jianxiu /Cheng Jinke/Chen Guoqiang from Shanghai Jiaotong University School of Medicine published in Nature Communications the latest research results titled Hypoxia regulates overall mRNA homeostasis by inducing Met1-linked linear ubiquitination of AGO2 in cancer cells


    miRNA is a type of non-coding single-stranded small RNA with a length of about 19-25 nt and a conservative sequence that is widely present in eukaryotes.


    In this work, the author first found through RIP-seq/RNA-seq/miRNA-seq detection that under hypoxic conditions, the miRNA pathway is inhibited, and the degradation of its target mRNA is blocked, thereby showing an overall accumulation


    In summary, this study first puts forward the view that tumor hypoxia microenvironment regulates mRNA homeostasis, and reveals the dynamic regulation mechanism of hypoxia on the regulatory network of miRNAs from a new perspective, providing new ideas for tumor research


    Postdoctoral fellow Zhang Hailong , associate researcher Zhao Xian, and postdoctoral fellow Guo Yanmin of the Department of Biochemistry and Cell Molecular Biology, Shanghai Jiao Tong University School of Medicine are the co-first authors of the paper.


    Article link: https://



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.